ResultsIQ

ResultsIQ › Latest results › Gujarat Alkalies and Chemicals Limited

Gujarat Alkalies and Chemicals Limited Q1 FY27 results press release summary

NSE: GUJALKALI · BSE: 530001

Results press release of 23 Jul 2026, summarised by AI from the filing.

GACL reports highest-ever quarterly revenue of ₹1,224.84 cr in Q1 FY27, EBITDA up 83% to ₹229 cr.

Key takeaways

  1. Revenue Highest ever quarterly revenue of ₹1,224.84 cr (Q1 FY26: ₹1,073.45 cr, +14%).
  2. EBITDA EBITDA rose to ₹229 cr (Q1 FY26: ₹125 cr, +83%).
  3. Profit Before Tax Profit Before Tax rose to ₹110 cr (Q1 FY26: ₹10 cr, +1000%).
  4. Renewable energy Share of renewable energy increased to 59% from 39%, reducing energy costs.
  5. HCL synthesis unit Board granted in-principle approval for one more HCL synthesis Unit at Dahej with approximate project cost of ₹55 cr.

Original filing on BSE

Gujarat Alkalies and Chemicals Limited Q1 FY27 results

As filed: Revenue ₹1,245 cr (+13% year on year), EBITDA ₹222 cr (+88% year on year), PAT ₹55.0 cr, EBITDA margin 17.8% (+713 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹1,125 cr (+5% year on year), EBITDA ₹110 cr (−4% year on year), PAT ₹15.0 cr (+66% year on year), EBITDA margin 9.8% (−84 bps). Score 25 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it. EBITDA margin fell 84 bps year on year. Other income 221% of PBT. Tax rate 5%. Consolidated profit +66% but standalone -62%. Share price after the results: −9.3% in 27 days (Nifty 500: +0.6%).
  • Q3 FY26: Revenue ₹1,044 cr (+2% year on year), EBITDA ₹105 cr (+8% year on year), PAT −₹20.0 cr, EBITDA margin 10.0% (+61 bps). Score 15 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it. EBITDA margin rose 61 bps year on year. Other income 241% of PBT. Tax rate 188%. Revenue fell 4% from last quarter. Share price after the results: −4.4% in 28 days (Nifty 500: −4.1%).
  • Q2 FY26: Revenue ₹1,083 cr (+9% year on year), EBITDA ₹74.0 cr (−1% year on year), PAT ₹16.0 cr, EBITDA margin 6.8% (−74 bps). Score 40 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was below it. EBITDA margin fell 74 bps year on year. Other income 454% of PBT. Tax rate -23%. Share price after the results: −7.4% in 28 days (Nifty 500: +1.3%).
  • Q1 FY26: Revenue ₹1,105 cr (+13% year on year), EBITDA ₹118 cr (+57% year on year), PAT −₹14.0 cr, EBITDA margin 10.7% (+300 bps). Score 45 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was in line with it. EBITDA margin rose 300 bps year on year. Other income 80% of PBT. Profit fell 256% from last quarter. Share price after the results: +1.6% in 28 days (Nifty 500: +1.7%).
  • Q4 FY25: Revenue ₹1,075 cr (+7% year on year), EBITDA ₹114 cr (+293% year on year), PAT ₹9.0 cr, EBITDA margin 10.6% (+771 bps). Score 60 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was well above it. EBITDA margin rose 771 bps year on year. Other income 104% of PBT. Tax rate 4%. Share price after the results: −9.4% in 28 days (Nifty 500: +0.2%).
  • Q3 FY25: Revenue ₹1,029 cr (+12% year on year), EBITDA ₹97.0 cr (+300% year on year), PAT −₹11.0 cr, EBITDA margin 9.4% (+867 bps). Score 45 of 100, In line with trend. Revenue and EBITDA growth were well above the company's own trend. EBITDA margin rose 867 bps year on year. Other income 375% of PBT. Tax rate -100%.
  • Q2 FY25: Revenue ₹991 cr (+2% year on year), EBITDA ₹75.0 cr (+67% year on year), PAT −₹18.0 cr, EBITDA margin 7.6% (+293 bps). Score 15 of 100, Below trend. EBITDA margin rose 293 bps year on year. Other income 377% of PBT. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Gujarat Alkalies and Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.